Share

In This Section

Home / Resource Library Search

Resource Library Search Filter

Filter By Resource Library: Format Type
Filter By Resource Library: Topic

Resource Library Search

You searched for:
    Displaying results 101 - 113 of 113
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
The ASCO Expert Panel determined that the recommendations from the guideline, published in 2016, are clear, thorough, and based on the most relevant scientific evidence. ASCO fully endorsed the CAP-ASH guideline on initial diagnostic work-up of acute leukemia and included some discussion points according to clinical practice and updated literature.
The guideline provides a framework for the multiple steps, including laboratory testing, in the evaluation of acute leukemia samples. Some aspects of the guideline, especially molecular genetic testing in acute leukemia, are rapidly changing with new supportive literature, which will require on-going updates for the guideline to remain relevant.
The following is a list of facilities that are CLIA-certified and accept external MRD samples. Amgen neither recommends nor endorses, and may or may not have financial relationships with, any facility that appears on this list. This list is not intended to be a comprehensive list nor as a referral to any provider listed. If you would like to suggest a facility to be added to this list, please contact Amgen MedInfo at 800-77-AMGEN.
The International Myeloma Working Group has defined new response categories of minimal residual disease negativity, with or without imaging-based absence of extramedullary disease, to allow uniform reporting within and outside clinical trials. In this Review, we clarify several aspects of disease response assessment, along with endpoints for clinical trials, and highlight future directions for disease response assessments.
"From doctors to patients, the goal of these publications is to help anyone better understand aspects of myeloma. The information provided in the International Myeloma Working Group�s publications seeks to help guide patients and their doctors to treating myeloma in the most effective way for every individual case."
This booklet describes health insurance options and resources to help patients and their families who are coping with the financial aspects of cancer care.
The toolkit includes the following educational resource booklets: Multiple Myeloma Disease Overview, Multiple Myeloma Treatment Overview, Managing My Myeloma, Multiple Myeloma Caregiver Guide and The Path to Precision Medicine. The toolkit is available in English and Spanish and can be downloaded or order a copy through the mail.
    Displaying results 101 - 113 of 113
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6